PHARMACYTE BIOTECH, INC. Other Nonoperating Expense
PHARMACYTE BIOTECH, INC. (PMCB) reported Other Nonoperating Expense of $1.06 thousand for the 3-month period ending 2022-10-31, per its 10-Q filed 2022-12-14.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2022-12-14
- PHARMACYTE BIOTECH, INC. other nonoperating expense for the quarter ending 2022-10-31 was $1.06K, a 120.42% increase year-over-year.
- PHARMACYTE BIOTECH, INC. other nonoperating expense for the quarter ending 2022-07-31 was $3.91K, a 144.13% increase year-over-year.
- PHARMACYTE BIOTECH, INC. other nonoperating expense for the quarter ending 2022-04-30 was $1.57K.
- PHARMACYTE BIOTECH, INC. other nonoperating expense for the quarter ending 2022-01-31 was $630.00.
- PHARMACYTE BIOTECH, INC. other nonoperating expense for fiscal 2022 was $4.28K, a 260.52% increase from fiscal 2021.
- PHARMACYTE BIOTECH, INC. other nonoperating expense for fiscal 2021 was $1.19K.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2022-10-31 | $1.06K 10-Q · filed 2022-12-14 | $4.96K 10-Q · filed 2022-12-14 | $6.54K derived: sum of 3 quarters · filed 2022-12-14 | $7.17K derived: sum of 4 quarters · filed 2022-12-14 |
| 2022-07-31 | $3.91K 10-Q · filed 2022-09-14 | $5.48K derived: sum of 2 quarters · filed 2022-09-14 | $6.11K derived: sum of 3 quarters · filed 2022-09-14 | $6.59K derived: sum of 4 quarters · filed 2022-12-14 |
| 2022-04-30 | $1.57K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | $2.20K derived: sum of 2 quarters · filed 2022-07-28 | $2.68K derived: sum of 3 quarters · filed 2022-12-14 | $4.28K 10-K · filed 2022-07-28 |
| 2022-01-31 | $630.00 10-Q · filed 2022-03-15 | $1.11K derived: sum of 2 quarters · filed 2022-12-14 | $2.71K 10-Q · filed 2022-03-15 | $2.71K derived: sum of 4 quarters · filed 2022-12-14 |
| 2021-10-31 | $480.00 10-Q · filed 2022-12-14 | $2.08K 10-Q · filed 2022-12-14 | $2.08K derived: sum of 3 quarters · filed 2022-12-14 | $2.08K derived: sum of 4 quarters · filed 2022-12-14 |
| 2021-07-31 | $1.60K 10-Q · filed 2022-09-14 | $1.60K derived: sum of 2 quarters · filed 2022-09-14 | $1.60K derived: sum of 3 quarters · filed 2022-09-14 | |
| 2021-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | $0.00 derived: sum of 2 quarters · filed 2022-07-28 | $1.19K 10-K · filed 2022-07-28 | |
| 2021-01-31 | $0.00 10-Q · filed 2022-03-15 | $1.19K 10-Q · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |